Bill116th CongressFiled Aug 2, 2019Health
H.R. 4158
CURE High Drug Prices Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Aug 2, 2019)
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
What just happenedAug 5, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Pingree, Chellie [D-ME-1](D-ME)Sponsor
1committees4actions1related bills7subjects
- Introduced in HouseAug 2, 2019
- Aug 5, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Aug 2, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Aug 2, 2019IntroReferralIntro-H
Introduced in House
- Aug 2, 2019IntroReferral1000
Introduced in House